Fitch Rating

Fitch Revises Outlook on Jubilant Pharma to Negative, Affirms at 'BB' - Sakshi Post

Fitch Revises Outlook on Jubilant Pharma to Negative, Affirms at 'BB'

Feb 16, 2022
Fitch Ratings has revised the outlook on Singapore-based Jubilant Pharma Limited's (JPL) Long-Term Issuer Default Rating (IDR) to Negative, from Stable, and has affirmed the IDR at 'BB'.

Fitch Ratings: Robust Refining Margins Support Indian Downstream Firms’ Credit Profiles

Feb 09, 2022
Fitch Ratings-Mumbai: Strong refining margins and the likely inventory gains arising from increasing oil prices should offset the moderate marketing margins of Indian oil marketing companies (OMCs)...

Fitch Upgrades Tata Consultancy Services to A, Outlook Stable

Dec 16, 2021
Fitch Ratings - Hong Kong: Fitch Ratings has upgraded the Long-Term Foreign- and Local-Currency Issuer Default Ratings (IDR) on India-based IT service company, Tata Consultancy Services Limited (TCS...
- Sakshi Post

Indian Auto Loan ABS Outlook Revised to Neutral; Covid-19 Risk Remains

Dec 10, 2021
Fitch Ratings-Hong Kong: Fitch Ratings has revised our sector outlook on Indian auto loan ABS to neutral from deteriorating, driven by stable asset performance that is supported by the economic...
Fitch Affirms ICICI Bank at 'BB+'; Outlook Negative - Sakshi Post

Fitch Affirms ICICI Bank at 'BB+'; Outlook Negative

Nov 30, 2021
Fitch Ratings - Singapore/Mumbai - 29 Nov 2021: Fitch Ratings has affirmed ICICI Bank Limited's (ICICI) Long-Term Issuer Default Rating (IDR) at 'BB+'. The Outlook is Negative.
Fitch has come out with an estimate saying that the Indian banking system will require $90 billion in fresh capital under Basel-III by 2018-19 financial year.  - Sakshi Post

Basel-III May Result in Half of Banks Breach Capital Triggers 

Sep 12, 2016
Government has to restore market confidence
Back to Top